Ranbaxy Laboratories issued a recall of generic versions of the cholesterol drug Lipitor in the U.S. because of potential dosage issues, WSJ reported.» Read More
Soliris, the company's sole product on the market, is approved in the United States, the European Union and Japan for the two conditions. The drugmaker raised its full-year adjusted earnings forecast to $4.37- $4.47 per share from its previous estimate of $3.70- $3.80.
March 10- NII Holdings Inc, which provides telecom services under the Nextel brand in Latin America, said it hired financial firms for advise on a potential sale of the company and on ways to deal with its $5.79 billion debt load. NII is struggling to stem customer losses in Mexico and Brazil, where it faces intense competition.
Weekend data showed China's exports unexpectedly tumbled in February, with a near-20 percent year-on-year dip swinging the trade balance into deficit.
*Offered to let Casablanca appoint 2 independent directors. *Casablanca denies making a postponement request. Casablanca, Cliffs' fifth-largest shareholder with a 5.2 percent stake, wants Chief Executive Gary Halverson gone, and the company to spin off its "riskier" international operations from cash-generating U.S. assets.
VANCOUVER/ NEW DELHI, March 7- Petronas' plan to build a liquefied natural gas terminal on Canada's Pacific coast edged closer to reality on Friday, as the Malaysian energy giant secured a third equity and offtake partner for the massive gas export project.
March 7- Close-out retailer Big Lots Inc said same-store sales would stop falling in the current fiscal year as its investments to boost sales start paying off.
March 7- Shares of digital coupon company Coupons.com Inc nearly doubled in their trading debut, valuing the company at over $2.2 billion and underscoring the popularity of technology IPOs. Coupons.com is the third technology company to go public this year, after the successful debuts of Care.com Inc and Varonis Inc..
March 7- Shares of digital coupon company Coupons.com Inc rose as much as 84 percent in their trading debut on Friday, valuing the company at over $2 billion. The company, founded by Chief Executive Steven Boal at the peak of the dot-com boom in 1998, priced a more-than-expected 10.5 million shares at $16 each on Thursday, above the company's planned $12- $14 range.
March 7- Close-out retailer Big Lots Inc reported a better-than-expected adjusted profit for the holiday quarter, sending the company's shares up as much as 22 percent in early trading.
March 7- Close-out retailer Big Lots Inc reported a better-than-expected profit for the holiday quarter, sending its shares up as much as 13 percent in premarket trading. The company reported adjusted earnings of $1.45 per share from continuing U.S. operations. Analysts on average had expected $1.40 per share, according to Thomson Reuters I/B/E/S.
March 6- Shares of Pixelworks Inc, which makes chips for digital display, rose 54 percent a day after the company revealed that Apple Inc is among its largest customers.
March 6- Mining equipment maker Joy Global Inc said demand from miners for maintenance work was returning after more than a year of delay when its main customers struggled with a coal glut and weak prices. Joy Global's shares rose as much as 5.4 percent in early trading after the company also raised the lower end of its 2014 profit forecast range.
March 6- Endo International Plc said the U.S. Food and Drug Administration approved its thrice-rejected testosterone replacement therapy, Aveed, to treat male hypogonadism.
March 6- Endo Health Solutions Inc said the U.S. Food and Drug Administration approved its thrice-rejected testosterone drug, Aveed, to treat male hypogonadism. The health regulator rejected the drug last May, saying that Endo needed a better plan to manage the risks associated with the drug.
*India key focus of Obama's "rebalancing" towards Asia. NEW DELHI, March 6- The United States sought on Thursday to rebuild rocky ties with India, while stressing it would tackle differences "head on" in pursuit of its drive to quintuple bilateral trade in a decade.
MUMBAI, March 6- Sun Pharmaceutical Industries Ltd, India's biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of low-cost drugs, a senior executive said.
Panaji, India, March 6- A consortium led by Steel Authority of India Ltd, the country's second-biggest steelmaker, hopes to buy coal mines overseas in the next few months when it has completed due diligence on facilities in Indonesia, Mozambique and the United States.
LONDON, March 5- China's reaction to events in Ukraine will probably prove more important in the long run than the responses of the United States and the EU. China's response has been typically low key but the country's leaders have provided quiet support for Russian intervention and resisted attempts by Washington and Brussels to isolate Moscow.
March 4- Xoma Corp said it would not proceed with late-stage studies of its lead drug, gevokizumab, as a treatment for a form arthritis of the hand, after data from two mid-stage studies showed that the drug was not effective enough. Xoma said its analyses of the study did not show a significant drug-related benefit even after six months.
March 4- Oxygen Biotherapeutics Inc said the U.S. Food and Drug Administration had lifted an order imposed in 2008 suspending trials of its experimental brain injury drug, sending the company's shares up by more than a third in early trading.